[go: up one dir, main page]

MX2017007880A - Metodo para la produccion de un sistema de administracion farmaceutica. - Google Patents

Metodo para la produccion de un sistema de administracion farmaceutica.

Info

Publication number
MX2017007880A
MX2017007880A MX2017007880A MX2017007880A MX2017007880A MX 2017007880 A MX2017007880 A MX 2017007880A MX 2017007880 A MX2017007880 A MX 2017007880A MX 2017007880 A MX2017007880 A MX 2017007880A MX 2017007880 A MX2017007880 A MX 2017007880A
Authority
MX
Mexico
Prior art keywords
delivery system
pharmaceutical delivery
production
improving
pharmaceutical
Prior art date
Application number
MX2017007880A
Other languages
English (en)
Inventor
Huwyler Jörg
Stirnimann Tanja
Puchkov Maxim
Atria Susanna
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of MX2017007880A publication Critical patent/MX2017007880A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención se refiere a un método para la producción de un sistema de administración farmacéutica, al uso de un carbonato de calcio reaccionado en superficie para mejorar la friabilidad de un sistema de administración farmacéutica al igual que para mejorar la capacidad de flujo de un sistema de administración farmacéutica, y a un sistema de administración farmacéutica obtenido por el método.
MX2017007880A 2014-12-18 2015-12-16 Metodo para la produccion de un sistema de administracion farmaceutica. MX2017007880A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP14199037.4A EP3034070A1 (en) 2014-12-18 2014-12-18 Method for the production of a pharmaceutical delivery system
US201462095865P 2014-12-23 2014-12-23
US201562232516P 2015-09-25 2015-09-25
PCT/EP2015/080016 WO2016096997A1 (en) 2014-12-18 2015-12-16 Method for the production of a pharmaceutical delivery system

Publications (1)

Publication Number Publication Date
MX2017007880A true MX2017007880A (es) 2017-09-05

Family

ID=52338877

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017007880A MX2017007880A (es) 2014-12-18 2015-12-16 Metodo para la produccion de un sistema de administracion farmaceutica.

Country Status (18)

Country Link
US (1) US20190022012A1 (es)
EP (2) EP3034070A1 (es)
JP (1) JP2017538733A (es)
KR (1) KR20170098894A (es)
CN (1) CN107106498A (es)
AR (1) AR103077A1 (es)
AU (1) AU2015367524B2 (es)
BR (1) BR112017012665A2 (es)
CA (1) CA2969763A1 (es)
CO (1) CO2017005500A2 (es)
CR (1) CR20170236A (es)
MX (1) MX2017007880A (es)
PH (1) PH12017501035A1 (es)
RU (1) RU2693491C2 (es)
SG (1) SG11201704513VA (es)
TW (1) TW201627009A (es)
UY (1) UY36444A (es)
WO (1) WO2016096997A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
EP3260114A1 (en) 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3260115A1 (en) 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
EP3275537A1 (en) * 2016-07-25 2018-01-31 Omya International AG Surface-modified calcium carbonate as carrier for transition metal-based catalysts
EP3520798A1 (en) * 2018-01-31 2019-08-07 Omya International AG Use of functionalized calcium carbonate as active ingredient
EP3982935A1 (en) 2019-06-17 2022-04-20 DSM IP Assets B.V. Composition comprising metformin hci, vitamin b12 and at least one flow additive
US20210059932A1 (en) * 2019-08-28 2021-03-04 Vincent Langlois Multi-layer edible strip containing active medicinal ingredients
CN111419815B (zh) * 2020-04-23 2022-03-11 永信药品工业（昆山）股份有限公司 依托考昔片及其优化方法
TW202200206A (zh) 2020-04-28 2022-01-01 瑞士商歐米亞國際公司 包含表面反應碳酸鈣作為賦形劑之顆粒
GB202007670D0 (en) * 2020-05-22 2020-07-08 Glaxosmithkline Consumer Healthcare Holdings Us Llc Pharmaceutical composition
EP3928859A1 (en) * 2020-06-23 2021-12-29 Omya International AG Surface-reacted calcium carbonate in a process for the production of a loaded microcapsule
CN116348134A (zh) * 2020-10-23 2023-06-27 河谷控股Ip有限责任公司 用于黏膜免疫应答的疫苗组合物
CN113413388B (zh) * 2021-06-30 2022-11-15 上海奥全生物医药科技有限公司 含有枸橼酸西地那非的药物组合物、制备方法及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5512411B2 (es) 1974-03-12 1980-04-02
US4451260A (en) 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
US4985459A (en) 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
JPS6143108A (ja) 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
DK162986A (da) 1985-04-12 1986-10-13 Forest Laboratories Terapeutisk middel i enhedsdosisform
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
GB8809421D0 (en) 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
US6312726B1 (en) 1993-08-20 2001-11-06 Nippon Shinyaku Co., Ltd. Gastric remaining preparation, swollen molding, and production process
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
US6582738B2 (en) 1999-09-13 2003-06-24 Deseret Laboratories, Inc. Process for preparing chewing gum containing a nutritional supplement
ES2292414T3 (es) * 2000-07-27 2008-03-16 Roquette Freres Granulos a base de almidon y de lactosa.
US7501409B2 (en) * 2000-09-06 2009-03-10 Mitsubishi Tanabe Pharma Corporation Preparations for oral administration
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US20030157213A1 (en) 2002-02-19 2003-08-21 Jeffrey Jenkins Nutrient chewing gum
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2881957B1 (fr) * 2005-02-16 2008-08-08 Solvay Comprimes comprenant une substance biologiquement active et un excipient
EP2070991B1 (en) 2007-12-12 2010-09-08 Omya Development AG Process to make surface-reacted precipitated calcium carbonate
EP2168572A1 (en) * 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
SI2264109T1 (sl) 2009-06-15 2012-07-31 Omya Development Ag Postopek za pripravo površinsko reakcijsko obdelanega kalcijevega karbonata in njegova uporaba
ME01441B (me) 2009-06-15 2012-12-31 Omya Development Ag Postupak za dobijanje površinski izreagovanog kalcijum karbonata primenom slabe kiseline
SI2679638T1 (sl) 2012-06-28 2015-11-30 Omya International Ag Vodna mineralna in/ali polnilna in/ali pigmentna suspenzija z visoko vrednostjo trdnih delcev v kislinskem ph okolju
PL2719376T3 (pl) * 2012-10-12 2015-08-31 Omya Int Ag Gastroretencyjny preparat leku oraz sposoby dostarczania i sposób jego wytwarzania z użyciem funkcjonalizowanego węglanu wapnia
DK2719373T3 (en) * 2012-10-12 2017-07-03 Omya Int Ag Fast dissolving solid dosage formulation comprising functionalized calcium carbonate and process for the preparation thereof
EP2810656B1 (en) * 2013-06-06 2017-08-02 Zentiva, a.s. Agomelatine formulations comprising agomelatine in the form of co-crystals
RU2646113C1 (ru) * 2016-09-06 2018-03-01 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Способ получения системы доставки фрагментов нуклеиновых кислот в клетки млекопитающих

Also Published As

Publication number Publication date
US20190022012A1 (en) 2019-01-24
UY36444A (es) 2016-04-29
WO2016096997A1 (en) 2016-06-23
PH12017501035A1 (en) 2018-03-05
TW201627009A (zh) 2016-08-01
EP3034070A1 (en) 2016-06-22
AU2015367524B2 (en) 2018-03-15
BR112017012665A2 (pt) 2017-12-26
JP2017538733A (ja) 2017-12-28
CN107106498A (zh) 2017-08-29
RU2017125320A3 (es) 2019-01-18
CA2969763A1 (en) 2016-06-23
AU2015367524A1 (en) 2017-07-20
KR20170098894A (ko) 2017-08-30
CR20170236A (es) 2017-09-26
CO2017005500A2 (es) 2017-09-29
AR103077A1 (es) 2017-04-12
RU2017125320A (ru) 2019-01-18
SG11201704513VA (en) 2017-07-28
EP3233062A1 (en) 2017-10-25
RU2693491C2 (ru) 2019-07-03

Similar Documents

Publication Publication Date Title
PH12017501035A1 (en) Method for the production of a pharmaceutical delivery system
TW201613859A (en) Analogs of PRIDOPIDINE, their preparation and use
PH12016502586A1 (en) Lipid comprising docosapentaenoic acid
MX2017003131A (es) Metodo para la preparacion de 2-alcoxi ciclohexanol.
MY190659A (en) Method for producing biohydrocarbons
JO3487B1 (ar) تخليق كوبانليسيب وملح الدايهيدروكلوريد الخاص به
PH12017501678A1 (en) Recombinant microorganism for improved production of finie chemicals
MA40313A (fr) Composition pharmaceutique à base d'isotrétinoïne destinée à la voie orale
MX2020009444A (es) Composicion farmaceutica oral de isotretinoina con dosis baja y su proceso de preparacion.
MX376782B (es) Métodos de administración de composiciones de amantadina.
IN2014MU00455A (es)
MX2017001487A (es) Sofosbuvir en forma cristalina y proceso para su preparacion.
MX2017005630A (es) Metodo para preparar bifenilaminas a partir de azobencenos mediante catalisis de rutenio.
MX2016017367A (es) Dioxido de zirconio, producto refractario, uso de dioxido de zirconio, procedimiento para la fabricacion de un producto refractario asi como un producto refractario fabricado mediante el mismo.
MX2016015465A (es) Composicion farmaceutica oral de isotretinoina.
MX2017001331A (es) Composicion farmaceutica oral de isotretinoina.
PH12018502350A1 (en) Method for the production of molded bodies for administration to animals
IN2014CH00304A (es)
EA038364B9 (ru) Способ получения гидролизата биомассы с пониженным содержанием солей
MX382631B (es) Proceso para la preparacion de derivados dihidroisoxazol.
MX2017004770A (es) Formas solidas del clorhidrato de nilotinib.
MY175821A (en) Microorganism having ability to produce o-succinylhomoserine or succinic acid, and method for producing succinic acid or o-succinylhomoserine by using same
MY177218A (en) Method for producing specific ?,?-unsaturated aldehydes by rearrangement process
MY187078A (en) Process of production of 7,8-dihydro-c15-aldehyde
IN2014CH01391A (es)